Patients’ perspective on aspirin during pregnancy: a survey

Jeske M. bij de Weg, Carolien N.H. Abheiden, Marjon A. de Boer, Conni de Groot, Johanna I.P. de Vries

Research output: Contribution to journalArticleAcademicpeer-review

2 Citations (Scopus)


Objective: To elucidate patients’ knowledge and counseling perspective on aspirin reducing the risk of hypertensive disorders of pregnancy (HDP). Methods: A quantitative survey was performed including women who are members of the patient orgasnization Dutch HELLP Foundation due to a history of HDP. Results: Awareness of the risk-reducing effect of aspirin on HDP was present in 51.9% of the 189 women. The majority was informed by their gynecologist (89.8%) and preferred to be informed by a gynecologist (79.4%), at the postpartum checkup (42.3%) or in the consecutive pregnancy (30.7%), both orally and written (62.4%). Conclusion: Half of the women with a history of HDP were aware of the risk-reducing effect of aspirin in a consecutive pregnancy.

Original languageEnglish
Pages (from-to)371-378
Number of pages8
JournalHypertension in pregnancy
Issue number4
Publication statusPublished - Nov 2020


  • Aspirin
  • gestational hypertension
  • placenta
  • preeclampsia

Cite this